PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
5.45
0.00 (0.00%)
Jun 5, 2026, 4:00 PM EDT - Market closed
PAVmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.09 | 0.07 | 3 | 2.45 | 0.38 | 0.5 | |
Revenue Growth (YoY) | -95.73% | -97.63% | 22.14% | 550.40% | -24.60% | - |
Cost of Revenue | 0.28 | 0.22 | 4.84 | 6.42 | 3.61 | 0.59 |
Gross Profit | -0.19 | -0.15 | -1.85 | -3.97 | -3.24 | -0.09 |
Selling, General & Admin | 19.11 | 17.17 | 36.15 | 48.53 | 60.73 | 34.32 |
Depreciation & Amortization Expenses | - | - | 0.56 | 2.02 | 1.78 | 0.15 |
Research & Development | 5.09 | 4.49 | 5.93 | 14.28 | 25.34 | 19.85 |
Total Operating Expenses | 24.2 | 21.66 | 42.64 | 64.83 | 87.85 | 54.31 |
Operating Income | -24.4 | -21.81 | -44.49 | -68.8 | -91.09 | -54.39 |
Interest Income | 0.04 | 0.03 | 0.25 | 0.51 | 0.17 | - |
Interest Expense | -0 | -0.02 | -0.05 | - | - | - |
Other Non-Operating Income (Expense) | 6.96 | 19.33 | 72.71 | - | - | - |
Total Non-Operating Income (Expense) | 6.99 | 19.34 | 72.91 | 0.51 | 0.17 | - |
Pretax Income | -1.06 | -2.47 | 28.43 | -68.29 | -90.92 | -54.39 |
Net Income | -22.16 | -2.47 | 28.43 | -79.26 | -103.24 | -56.13 |
Minority Interest in Earnings | -3.53 | -2.87 | -11.36 | -15.09 | -14.26 | -5.78 |
Net Income Attributable to Preferred Dividends | 6.36 | 4.18 | 7.83 | - | - | - |
Earnings From Discontinued Operations | 2.76 | - | - | - | - | - |
Net Income to Common | -1.32 | 0.4 | 39.79 | -66.27 | -89.26 | -50.63 |
Net Income Growth | - | -98.99% | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | 0 |
Shares Change (YoY) | 35.11% | - | 178.12% | 21.78% | 14.91% | 63.42% |
EPS (Basic) | -29.27 | -5.63 | 99.15 | -170.70 | -450.90 | -189.00 |
EPS (Diluted) | -37.37 | -5.63 | 14.90 | -274.80 | -450.90 | -189.00 |
Free Cash Flow | -6.29 | -5.24 | -33.61 | -52.28 | -72.53 | -42.06 |
Free Cash Flow Per Share | -6.78 | -7.81 | -50.13 | -216.86 | -366.39 | -244.17 |
Gross Margin | -227.06% | -207.04% | -61.60% | -161.83% | -858.62% | -17.00% |
Operating Margin | -28702.40% | -30712.70% | -1485.38% | -2805.67% | -24161.00% | -10878.60% |
Profit Margin | -26065.90% | -3477.46% | 949.15% | -3232.59% | -27384.10% | -11225.20% |
FCF Margin | -7402.35% | -7376.06% | -1122.17% | -2132.06% | -19237.40% | -8412.00% |
EBITDA | -24.32 | -21.7 | -43.29 | -65.86 | -88.63 | -54.17 |
EBITDA Margin | -28605.90% | -30564.80% | -1445.38% | -2686.09% | -23509.30% | -10833.40% |
EBIT | -24.4 | -21.81 | -44.49 | -68.8 | -91.09 | -54.39 |
EBIT Margin | -28702.40% | -30712.70% | -1485.38% | -2805.67% | -24161.00% | -10878.60% |